GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed price. Currency in GBp
Add to watchlist
At close: 05:12PM BST
| Previous close | 1,731.60 |
| Open | 1,748.00 |
| Bid | 1,763.40 x 0 |
| Ask | 1,763.60 x 0 |
| Day's range | 1,741.80 - 1,772.00 |
| 52-week range | 1,215.83 - 1,817.00 |
| Volume | |
| Avg. volume | 10,891,056 |
| Market cap | 89.681B |
| Beta (5Y monthly) | 0.29 |
| PE ratio (TTM) | 17.48 |
| EPS (TTM) | 100.90 |
| Earnings date | 27 Jul 2022 |
| Forward dividend & yield | 0.75 (4.25%) |
| Ex-dividend date | 19 May 2022 |
| 1y target est | 1,805.18 |
- Zacks
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck, and Glaxo
Eli Lilly, Novo Nordisk, Merck, and Glaxo are part of Zacks Industry Outlook article.
- Zacks
Top Analyst Reports for Apple, Berkshire Hathaway, & S&P Global
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Berkshire Hathaway Inc. (BRK.B), and S&P Global Inc. (SPGI).
- Zacks
4 Large Drug Stocks to Watch as the Industry Recovers
Drug/biotech companies are likely to see significant advances in innovation in 2022. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and Glaxo (GSK) are worth retaining in your portfolio.
© 2022 Yahoo. All rights reserved.
